EGFR-TARGETED SELECTIVE GENE THERAPY FOR NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Yamaguchi, Miki [1 ]
Nakamura, Kiminori [1 ]
Sakuragi, Naoya [1 ]
Kato, Kazunori [1 ]
Hamada, Hirofumi [1 ]
机构：
[1] Sapporo Med Univ, Sch Med, Dept Mol Med, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF GENE MEDICINE | 2010年 / 12卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1056 / 1057
页数：2
相关论文
共 50 条
  • [1] Metabolic approach to EGFR-targeted therapy in non-small cell lung cancer
    Kam, Yoonseok
    Swain, Pamela
    Romero, Natalia
    Dranka, Brian P.
    CANCER RESEARCH, 2019, 79 (13)
  • [2] EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
    Antonicelli, Alberto
    Cafarotti, Stefano
    Indini, Alice
    Galli, Alessio
    Russo, Andrea
    Cesario, Alfredo
    Lococo, Filippo Maria
    Russo, Patrizia
    Mainini, Alberto Franco
    Bonifati, Luca Giuseppe
    Nosotti, Mario
    Santambrogio, Luigi
    Margaritora, Stefano
    Granone, Pierluigi Maria
    Dutly, Andre Emanuel
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (03): : 320 - 330
  • [3] Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyond
    Delaney, Christopher
    Frank, Samuel
    Huang, R. Stephanie
    CHINESE JOURNAL OF CANCER, 2015, 34
  • [4] Non-small cell lung cancer: an update on emerging EGFR-targeted therapies
    Favorito, Valentina
    Ricciotti, Ilaria
    De Giglio, Andrea
    Fabbri, Laura
    Seminerio, Renata
    Di Federico, Alessandro
    Gariazzo, Eleonora
    Costabile, Silvia
    Metro, Giulio
    EXPERT OPINION ON EMERGING DRUGS, 2024, 29 (02) : 139 - 154
  • [5] Current perspectives on the use of miRNA as a biomarker for EGFR-targeted therapy for non-small cell lung cancer
    Florczuk, Mateusz
    Szpechcinski, Adam
    Chorostowska-Wynimko, Joanna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2017, 71 : 1207 - 1218
  • [6] 11C-PD153035 PET/CT molecular imaging of EGFR for evaluation of advanced non-small cell lung cancer (NSCLC) to EGFR-targeted therapy
    Meng, X., Jr.
    Yu, J. M.
    Yang, G. R.
    Zhao, S. Q.
    Sun, X. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Implications of the success of EGFR-targeted therapy in advanced non-small cell lung cancer for its application to the adjuvant setting
    Takeda, Masayuki
    JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4553 - 4555
  • [8] Biomarkers for targeted therapy selection in non-small cell lung cancer (NSCLC)
    Paz-Ares, L.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S4 - S4
  • [9] NOVEL EGFR TARGETED THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER
    Yamamoto, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 81 - 81
  • [10] Targeted therapy for non-small cell lung cancer: beyond EGFR and VEGF
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S220 - S221
12345